News Daily News Italian Registry Cautions Against TAVR in Low-Risk Patients L.A. McKeown May 16, 2016
News Daily News Study Supports Safety of Forgoing ICU Stay After TAVR in Selected Patients Todd Neale April 27, 2016
News Conference News ACC 2016 Self-Expanding Transcatheter Valve Maintains Advantage Over Surgery at 3 Years in High-Risk Elderly Patients L.A. McKeown April 04, 2016
News Conference News ACC 2016 Sapien 3 Superior to Surgery Among Intermediate-Risk Patients in Observational Trial Yael L. Maxwell April 03, 2016
News Daily News Risk Model Improves Practical Prediction of In-Hospital Mortality After TAVR L.A. McKeown March 08, 2016
News Industry News Medtronic Enrolls First Patients in Clinical Study to Evaluate the CoreValve(TM) Evolut(TM) R System in 'Real-World' Setting March 06, 2016
News Daily News Study Pinpoints Predictors of New Conduction Abnormalities, Pacemaker With Sapien 3 L.A. McKeown February 07, 2016
Presentation Predictors of Permanent Pacemaker Implantations and New-Onset Conduction Abnormalities With Sapien 3 Presenter: Oliver Husser February 04, 2016
News Daily News A-Fib Diagnosis After TAVR, Particularly When New-Onset, Associated With Higher Risk of Mortality Michael O'Riordan January 18, 2016
News Daily News German Data Show Impact of TAVR Introduction on Clinical Practice Patterns L.A. McKeown December 16, 2015
News Daily News Report Provides Snapshot of Initial Commercial TAVR Experience Todd Neale November 30, 2015
News Daily News The Next Frontier: Repositionable, Retrievable Transcatheter Valves Show Promise in Noncalcific Aortic Regurgitation Yael L. Maxwell November 24, 2015
News Conference News TCT 2015 Valve-in-Valve TAVR Benefits Patients with Failing Surgical Bioprosthetic Valves Todd Neale October 15, 2015
News Conference News TCT 2015 Low 1-Year Event Rates Seen After TAVR With Sapien 3 Todd Neale October 15, 2015
News Conference News TCT 2015 First-in-Human Studies: Novel Devices for Aortic Valve Stenosis Safe, Feasible October 12, 2015
News Conference News TCT 2015 CoreValve Extreme Risk Pivotal Trial: Improved Benefits Confirmed After 3 Years October 12, 2015
News Conference News TCT 2015 Global TAVR Market Poised to Exceed DES Market by 2025 October 11, 2015
News Daily News In the Early Days of TAVR, No Mortality Penalty for Patients Treated Outside of Trial Centers October 01, 2015